Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This year tags : Product-news save search
Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Published: 2024-04-23 (Crawled : 00:00) - biospace.com/
MCUJF | $0.72 0% 9K
|
Health Technology
|
| O: -5.56%
H: 0.0%
C: 0.0%
fda designation for
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
|
| O: -40.0%
H: 33.33%
C: 0.0%
duexis
Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Published: 2024-03-26 (Crawled : 18:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 1.84%
H: 0.24%
C: -0.14%
adzynma japan takeda approval injection
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
PTGX S | $26.82 0.79% 0.78% 340K
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -1.48%
update therapeutics
BD Increases Domestic Production to Support U.S. Health Care Need for Syringes
Published: 2024-03-21 (Crawled : 12:00) - biospace.com/
BDX | $234.36 0.21% 0.0% 800K
|
Health Technology
|
| O: 0.46%
H: 1.26%
C: 1.11%
health care
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
Published: 2024-03-13 (Crawled : 11:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 1.0%
H: 1.41%
C: -0.25%
disease pneumococcal children
Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®
Published: 2024-02-29 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.56%
H: 0.12%
C: -0.38%
stelara biosimilar market
Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
TSOI | $0.0007 0.0% 23M
|
Manufacturing
|
| O: 11.11%
H: 0.0%
C: -10.0%
international cell solutions
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
Published: 2024-02-19 (Crawled : 09:00) - biospace.com/
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
lung license cancer cell application advanced
InnoCare Announces First Prescription of Tafasitamab in Combination with Lenalidomide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Under Greater Bay Area’s Early Access Program
Published: 2024-01-22 (Crawled : 07:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.56%
H: 1.97%
C: 1.37%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 0.11%
H: 1.96%
C: -0.27%
first bay program
Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic Carcinomas of the Head and Neck
Published: 2024-01-18 (Crawled : 11:00) - biospace.com/
AGEN A | $6.44 11.61% 10.4% 1.7M
|
Health Technology
|
| O: 1.78%
H: 0.88%
C: -6.95%
obt076 first trial
Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
Published: 2024-01-17 (Crawled : 14:30) - biospace.com/
XBIO | $3.76 7.32% 2.7K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.37%
research agreement platform
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.